Navigation Links
NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
Date:11/4/2008

anti-inflammatory agents, which is in phase 3 clinical studies for the treatment of the signs and symptoms of osteoarthritis, with final phase 3 results anticipated in 2008.

Beyond naproxcinod, NicOx has a pipeline containing multiple nitric oxide-donating NCEs, which are in development internally and with partners, including Pfizer Inc and Merck & Co., Inc., for the treatment of prevalent and underserved diseases, such as atherosclerosis, hypertension, widespread eye diseases and Chronic Obstructive Pulmonary Disease (COPD).

NicOx S.A. is headquartered in France and is listed on the Euronext Paris Stock Exchange (Compartment B: Mid Caps).

This press release contains certain forward-looking statements. Although the Company believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ materially from those anticipated in the forward-looking statements.

For a discussion of risks and uncertainties which could cause actual results, financial condition, performance or achievements of NicOx S.A. to differ from those contained in the forward-looking statements, please refer to the Risk Factors ("Facteurs de Risque") section of the Document de Reference filed with the AMF, which is available on the AMF website ( http://www.amf-france.org) or on NicOx S.A.'s website (http://www.nicox.com).

http://www.nicox.com


'/>"/>
SOURCE NicOx
Copyright©2008 PR Newswire.
All rights reserved

1082

GOOD

Page: 1 2 3 4

Related medicine technology :

1. NicOx Announces Second Naproxcinod Pivotal Phase 3 Study (302) Meets Efficacy Primary Endpoints and Supports Non-Detrimental Blood Pressure Effect
2. NicOx Announces Top-Line Results From Naproxcinod 52-Week 301 Safety Extension
3. NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients
4. NicOx Announces Blood Pressure Analysis From 301 Phase 3 Study for Naproxcinod at EULAR
5. NicOx Completes Patient Enrollment in Third Naproxcinod Pivotal Phase 3 Study
6. NicOx Announces Initiation of First Phase 1 Study of Investigational Nitric Oxide-Donating Agent in Hypertensive Patients by Merck & Co., Inc.
7. Financial Results for Full Year 2007: NicOx Significantly Advances Clinical Programs
8. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
9. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
10. NicOx Announces TOPIGEN Initiates Phase 2 Proof of Concept Study in COPD for TPI 1020
11. NicOx Naproxcinod Phase 3 Results Presented at American College of Rheumatology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... N.C. , Sept. 12, 2014 ... device companies increasingly depend upon Health Outcomes Liaison ... with payer organizations, thought leaders, and other important ... and comparative effectiveness data grows, successful companies will ... relatively new field-based HOL function. To ...
(Date:9/12/2014)... 12, 2014 Research ... addition of the  "Patient Handling Equipment Market ... & by End User - Global Forecast ... ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... lucrative growth potential for the next five ...
(Date:9/12/2014)... -- The report "Food & Beverage ... & Energy Drinks, Others), Food (Fruit & Vegetable, ... Material (Aluminum & Steel) - Global Forecast to ... Food & Beverage Metal Cans Market with analysis ... volumes and values. The application market is sub-segmented ...
Breaking Medicine Technology:Pharmaceutical Sector Turning to Health Outcomes Liaisons to Help Industry Navigate Payer-Focused Marketplace 2Global Patient Handling Equipment (Wheelchair, Scooter, Beds, Bathroom Safety, Mechanical, Ambulatory) Market - Forecast to 2019 2Global Patient Handling Equipment (Wheelchair, Scooter, Beds, Bathroom Safety, Mechanical, Ambulatory) Market - Forecast to 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4
... XIANYANG, China, Oct. 7 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, ... Company"),a Xianyang-based developer, manufacturer and supplier of pharmaceutical,products ... and,conditions, today announced that the Chinese Military Drug ... the Company,s new drug,application, the Zushima Analgesic Aerosol ...
... Oct. 7 Cleveland Clinic,s Top 10 Medical ... techniques and therapies that are being developed to treat everything ... , The list of breakthrough devices and therapies was ... and it was unveiled during Cleveland Clinic,s 2009 ...
Cached Medicine Technology:Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray 2Biostar Pharmaceuticals, Inc. Receives the Chinese Military Drug Administration Clearance to Begin Clinical Trial for Zushima Analgesic Aerosol Spray 3Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 2Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 3Cleveland Clinic Unveils 'Top 10' Medical Innovations for 2010 4
(Date:9/14/2014)... 14, 2014 Top10BestSEOHosting.com always offers ... many web host suppliers carefully, the site has ... GoDaddy are the Best WordPress Hosting suppliers in ... as a top web hosting provider, and the ... a web hosting provider known for its flexible ...
(Date:9/14/2014)... September 14, 2014 UWDress.com, is an ... industry, has recently announced its new range of ... and bring more benefits to worldwide ladies, the company ... including lace wedding outfits, blue evening gowns, black formal ... to 70 percent off. , The company’s senior ...
(Date:9/13/2014)... BC (PRWEB) September 13, 2014 ... Center, a renowned Vancouver chiropractic clinic, has recently ... medicine. In this latest blog on the topic, ... and clarified several myths that people have regarding ... difference between the services of a chiropractor and ...
(Date:9/13/2014)... Researchers say they,ve tracked specific activity in the human ... whether imagination and memory were distinct processes, so a ... to explore the issue. "I was thinking a ... myself in the future, and I started wondering how ... said in a university news release. "I wondered ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 Top10BestSEOHosting.com ... has recently compared a lot of web hosting ... Hostgator and Arvixe are the best ASP.NET hosting ... of Top10BestSEOHosting.com, ASP.NET hosting is a very popular ... XML websites. , The IT manager is happy ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: The Best Linux Web Hosting Suppliers Now Unveiled 2Health News:UWDress.com: Elegant Cocktail Dresses Under $100 Now Offered 2Health News:East Vancouver Chiropractor Releases Blog to Bust Myths about Chiropractic Medicine 2Health News:Scientists Watch Imagination at Work in the Brain 2Health News:Best ASP.NET Hosting Suppliers in 2014 Unveiled By Top10BestSEOHosting.com 2
... of Australias leading life scientists have been chosen from ... in an initiative by Merck Sharp & Dohme and ... biopharmaceutical industry. , Antisense Therapeutics Ltd (ASX code: ... Director Dr Raisa Monteiro have been selected as joint ...
... properties of bitter melon, a vegetable and traditional Chinese ... 2 diabetes. , Teams from the Garvan Institute of ... pulped roughly a tonne of fresh bitter melon and ... all appear to activate the enzyme AMPK, a protein ...
... Cowden Associates Finds High-Deductible Health Plans Not the Solution for ... ... 27 Employers in Pennsylvania, West,Virginia and Ohio believe the future ... health through wellness programs,according to Cowden Associates, Inc. Seventh Annual Tri-State ...
... 27 Ethicon Endo-Surgery announced,today that the ... application,to the U.S. Food and Drug Administration ... personalized sedation (CAPS) system., The SEDASYS(TM) ... teams to,administer minimal to moderate propofol sedation ...
... Software Introduces Comprehensive Patient and Information Tracking System with Automatic ... ... DALLAS, March 27 Eklin Medical Systems, a leading,developer of digital ... for veterinary care,(VIA(R)), is showcasing VIA,s new Hospital Functionality and VIA ...
... their children are often involved in caring ... -- Alzheimer,s care in the United States is a ... five so-called "sandwich" caregivers who look after a relative ... with care duties, ranging from attending doctors, appointments to ...
Cached Medicine News:Health News:Rising Australian biotech stars set to connect on the world stage 2Health News:A ton of bitter melon produces sweet results for diabetes 2Health News:Survey Highlights Ongoing Shift To Wellness to Manage Health Care Costs 2Health News:Survey Highlights Ongoing Shift To Wellness to Manage Health Care Costs 3Health News:Ethicon Endo-Surgery Submits Application to FDA for Approval of the SEDASYS(TM) System - the First Computer-Assisted Personalized Sedation System 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 2Health News:Eklin VIA(R) Showcases Hospitalization Functionality to Veterinary Care Market 3Health News:With Alzheimer's, It Takes a Family 2Health News:With Alzheimer's, It Takes a Family 3
... continues to raise the standard for rapid, ... x g performance and our new 4x5mL ... sizes from 0.2 ml to 8.3 ml, ... drive, very quiet operation, rotor imbalance detection, ...
... has the highest g-force ever. But optimal ... force. Optima MAX combines maximum force, capacity, ... performance that's worlds apart from any other ... and enhanced efficiency, Optima takes productivity to ...
... environmental safety are the hallmarks ... Ultracentrifuge from Beckman Coulter. With ... technology, the LE-80 K is ... advanced capability for your laboratory ...
... of generating 694,000 x g ... rpm, Beckman Coulter's Optima L-90K ... more separations in less time. ... with a broad range of ...
Medicine Products: